# FDA Inspection 1237979 - TriHealth IRB - April 18, 2024

Source: https://www.keypedia.com/records/fda_inspections/trihealth-irb/46ebac7e-4a9b-49e8-ae0a-d38eba7e0bcc
Source feed: FDA_Inspections

> FDA Inspection 1237979 for TriHealth IRB on April 18, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1237979
- Company Name: TriHealth IRB
- Inspection Date: 2024-04-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1237979 - 2024-04-18](https://www.keypedia.com/records/fda_inspections/trihealth-irb/61ddad8e-6af1-47c0-ba3d-46cd762c7eff)
- [FDA Inspection 1237979 - 2024-04-18](https://www.keypedia.com/records/fda_inspections/trihealth-irb/17630997-b6d1-4b17-94ee-21a5d16194ce)
- [FDA Inspection 946074 - 2015-10-14](https://www.keypedia.com/records/fda_inspections/trihealth-irb/aa52d7f6-4802-4cff-8bb5-b980834db5d8)
- [FDA Inspection 826247 - 2013-04-08](https://www.keypedia.com/records/fda_inspections/trihealth-irb/42b5c70a-0e76-4b54-9f69-013831eca6ed)

Company: https://www.keypedia.com/companies/trihealth-irb/1b0b85ec-a6ce-4e9c-87cd-c3d9fd304fe8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
